Lamictal Bipolar Observational Study

NCT00460226 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2012-03-19

No results posted yet for this study

Summary

This is multi-center, prospective, observational stud. This study is designed to evaluate the rate of non-serious rash in Korean bipolar I patients.

Conditions

Interventions

DRUG

lamotrigine

lamotrigine treatment for 12weeks

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-12-31
Completion
2007-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460226 on ClinicalTrials.gov